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Abstract
Levodopa is a dopamine replacement medication administered to patients with Parkinson’s disease (PD) to alleviate their motor symptoms. However, its long-term use can cause adverse side
effects, including involuntary motor movements. We studied 16 PD patients before and after
taking Levodopa based on resting-state electroencephalography (EEG) recordings to determine
how Levodopa affects the functional connectivity of their brain networks. We used several metrics from graph theory, in particular the minimum spanning tree (MST) metric, and analyzed
how they change after subjects take Levodopa. We observed significant changes in the lower
α band toward a more path-like and less globally efficient network after Levodopa intake. We
also observed that changes in multiple network metrics after taking Levodopa correlate with
changes in the unified Parkinson’s disease rating scale (UPDRS) scores of PD patients in the
lower α and β bands.

Keywords: Resting-state EEG, Graph Analysis, Minimum Spanning Tree, Functional
Brain Connectivity, Parkinson’s disease, Levodopa
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Lay Summary
Parkinson’s disease (PD) is a brain disorder that severely disrupts the human body’s ability
to move and perform daily tasks. The slowness of movement and tremors are some of the
main visible symptoms of this disease, but PD can also cause dementia, depression, and sleep
disorders in patients. Even though PD is more prevalent in older people, individuals much
younger (in their forties) can also be diagnosed with PD. PD is a long-term disease, and its
symptoms worsen with time, significantly diminishing a patient’s quality of life. While there is
currently no cure for PD, there are medications to alleviate some of their symptoms, the most
important of which is Levodopa. Levodopa is a drug that is converted into dopamine in the
brain, which in PD patients is significantly reduced. Levodopa is usually the first treatment PD
patients receive, as it can alleviate their physical symptoms. As the disease progresses, patients
need to take higher doses of the medication. This can cause side effects such as involuntary
movements in the body, which some patients can also experience without the drug. In this
study, to better understand the conflicting effects of Levodopa, we use Electroencephalography (EEG) to record brain signals of patients before and after taking Levodopa. We then use
several mathematical methods from graph analysis, which were originally used to study social
networks. We use these methods to observe how interactions between different brain regions
change from a network point of view after taking Levodopa. Our methods show that Levodopa
makes the brain less efficient as a network, even though taking Levodopa reduces Parkinsonian
symptoms. We believe that these results can be used to provide an approach to adjust Levodopa
dosage and better understand the underlying changes in PD patients after taking Levodopa.
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Chapter 1
Introduction
1.1

Introduction

In this chapter, we begin by providing a background on PD, covering its prevalence, biological
underpinnings, symptoms, diagnosis, and treatments. Then, we introduce electroencephalography (EEG) functional connectivity and how graph theory has been used to study EEG data.
Then, we explain the main topic of our study, studying the effects of Levodopa on PD patients,
and discuss how a graph-based EEG study can be beneficial in this topic. Finally, we conclude
this chapter by outlining the thesis objectives and how different chapters are structured.

1.2

Parkinson’s Disease

Parkinson’s disease (PD) is a progressive neurodegenerative disorder manifested by a loss in
dopaminergic neurons. The Public Health Agency of Canada (PHAC) estimates that the number of PD patients will double between 2011 and 2031, making PD a significant health issue
considering the country’s ageing population [10, 11]. In a study of 84,000 PD patients in
Canada, PHAC reported that PD is more prevalent in men than women when adjusted for age.
It also stated that the number of new PD diagnoses in Canadians aged over 85 was 48 times
higher than in people in the 40-44 age group [11].
1

2

1.2.1

Chapter 1. Introduction

Symptoms of Parkinson’s Disease

PD symptoms encompass many cognitive, motor, and behavioural impairments, varying from
one patient to another. Motor impairments are PD’s earlier and more obvious symptoms,
including resting tremor, muscular rigidity, postural instability, and bradykinesia (abnormal
slowness of movement) [12, 13]. PD patients can also develop non-motor symptoms such as
dementia, sleep disorders, anxiety, and depression as the disease progresses [14].

1.2.2

Diagnosis of Parkinson’s Disease

The diagnosis of PD is currently made through clinical assessments, usually performed by a
movement disorders specialist. Clinicians mainly examine potential PD patients for any motor
symptoms and their medical history. They also look at brain imaging data and patients’ responsiveness to conventional PD treatments [13]. After a diagnosis for PD is made, it is crucial to
track the progression of the disease, something that is typically done through the Movement
Disorder Society-Sponsored Revision of the Unified Parkinson’s Disease Rating Scale (MDSUPDRS or UPDRS) [9]. UPDRS has multiple parts to evaluate patients’ behaviour, mood,
daily activities, and motor skills, among others (See Table. 1.1). Each part can have multiple
sub-scores, with motor evaluations having individual ratings for different extremities [9].

1.2.3

Classical Modelling of the Brain in PD

Research has shown that several PD symptoms, especially motor ones, result from the death
of dopaminergic neurons in the substantia nigra pars compacta (SNc), a component of the
Basal Ganglia (BG) in the brain. BG is known to play an essential role in facilitating motor
functions and cognitive functions such as memory and learning. Lacking direct control over
motor output, BG mainly uses the neurotransmitter dopamine to perform motor functions. BG
has multiple interconnected components: striatum, globus pallidus pars externa (GPe), globus
pallidus pars interna (GPi), substantia nigra pars reticulata (SNr), SNc, the subthalamic nucleus

1.2. Parkinson’s Disease

3

Table 1.1: Items covered in the MDS-UPDRS assessment for PD. The assessment is divided
into four parts, each covering a specific set of items. The clinician assesses the severity of PD
symptoms for each item by giving it a score between zero and four. Zero is for normal, while
four is for severe symptoms. These scores are then averaged based on factor weights provided
by the authors of MDS-UPDRS to give a score for each part and a total score for each patient.
Adapted from [9].
Part I:
Non-motor Aspects of
Experiences of
Daily Living

Hallucinations and
psychosis

Part II:
Motor Aspects of
Experiences of
Daily Living
Salivation and
drooling
Chewing and
swallowing

Depressed mood

Eating tasks

Rigidity of neck and
four extremities

Anxious mood

Dressing

Finger taps

Apathy

Hygiene

Hand movements

Handwriting

Pronation/supination

Turning in bed
Tremor
Walking and
balance
Freezing

Toe tapping
Leg agility

Cognitive impairment

Features of dopamine
dysregulation syndrome
Nighttime sleep problems
Daytime sleepiness
Pain and
other sensations
Urinary problems
Constipation problems
Lightheadedness
on standing
Fatigue

Part III:
Motor
Examination
Speech
Facial expression

Arising from chair
Gait
Freezing of gait
Postural stability
Posture
Postural tremor
of hands
Kinetic tremor
of hands
Rest tremor
amplitude
Constancy of
rest tremor

Part IV:
Motor
Complications
Time spent
with dyskinesia
Functional impact
of dyskinesia
Time spent in
the OFF state
Functional impact
of fluctuations
Complexity of
motor fluctuations
Painful OFF-state
dystonia

4
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Figure 1.1: The anatomy of the Basal Ganglia and its components. Adapted from [1, 2]
(STN) that process input from the cortex and project to the thalamus (See Fig. 1.1)
In classical modeling of BG (See Fig. 1.2(a)), a direct and an indirect pathway connect
its components. The direct pathway has an inhibitory effect on SNr and GPi activity, while
the indirect path has an excitatory effect on them. In the direct path, the striatum directly
inhibits SNr and GPi’s projection to the thalamus. In the indirect path, the striatum inhibits
GPe, which itself inhibits STN. STN then has an excitatory effect on SNr and GPi’s projection
to the thalamus. The balance between these two pathways, which is regulated by dopamine,
has proved to be essential in explaining how movement disorders affect the brain. In BG, SNc
neurons are responsible for releasing dopamine. Striatum has two sets of dopamine receptors
named D1 and D2, affecting the direct and indirect pathways [15, 16].
The loss of neurons on SNc causes a decrease in dopamine that the striatum receives, causing an excitatory effect on GPi and SNr and an inhibition on BG’s projection to the thalamus,
negatively affecting the motor skills of the patient. In other words, the dopamine deficiency in
the brain of PD patients causes an increase in the activity of neurons in the indirect path and a

1.3. Treatments for Parkinson’s Disease

(a) Healthy Brain State

5

(b) PD Brain State

Figure 1.2: BG pathways in healthy brains and PD brains. Excitatory and inhibitory projections are signified by pointed and blunted arrows, respectively. The thickness of each line is
proportional to the strength of that projection. Adapted from [3].
decrease in the activity of neurons in the direct path (See Fig. 1.2(b)). Treatments of PD have
to reverse these changes to restore the normal circuitry of the brain, alleviating symptoms of
PD. (See Fig. 1.2(b)) [15].

1.3
1.3.1

Treatments for Parkinson’s Disease
Levodopa

Currently, there is no cure for PD, and medical interventions focus on improving the quality
of life in patients by alleviating their symptoms. The two main treatments for PD are neurosurgical and pharmacological interventions [12]. In addition to these methods, physical and
speech therapy and palliative care can also help patients based on their needs and symptoms at
different stages of the disease [17].
As mentioned above, a hallmark of PD is the loss of dopaminergic neurons, which reduces

6
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dopamine production in the brain. This decrease in dopamine levels has been linked to motor
symptoms of PD. Thus, increasing dopamine levels through medication is a natural first step in
the treatment of PD. However, taking dopamine through medication will not help, as it cannot
pass through the blood-brain barrier and reach the brain. This necessitates finding alternative
pharmacological solutions to increase dopamine levels in PD patients [18].
Known as the golden standard of PD treatment, Levodopa is a dopamine precursor medication that patients take orally and can cross the blood-brain barrier to increase the dopamine
levels in the brain. Levodopa alleviates a wide range of PD symptoms, including motor impairments such as rigidity and bradykinesia [18]. When Levodopa is absorbed in the body and
enters the central nervous system, it is converted to dopamine through decarboxylation inside
the presynaptic terminals of striatal dopaminergic neurons. The produced dopamine is what
causes Levodopa to alleviate PD symptoms. However, the brain is not the only place where
this decarboxylation happens. Levodopa is readily decarboxylated to dopamine in different
parts of the body, especially the intestine. This peripheral conversion of Levodopa to dopamine
causes various adverse side effects, including nausea and hypotension [19]. Because of this,
Levodopa is combined with a DOPA decarboxylase inhibitors (DDCIs) such as benserazide
and carbidopa often as a single medication, which do not cross the blood-brain barrier and prevent metabolization of Levodopa outside the brain. In addition to carbidopa, some clinicians
also prescribe medications such as COMT inhibitors to reduce the degradation of Levodopa
further before it passes the blood-brain barrier [20, 18, 21, 19].
Adverse side-effects of Levodopa have led clinicians to use alternative pharmacological
treatments such as Monoamine oxidase B (MAO-B) inhibitors and Dopamine agonists, used
on their own and in conjunction with Levodopa. MAO-B is an enzyme that causes oxidative
metabolism of dopamine in the striatum, so inhibiting its activity increases dopamine levels in
the SN. Dopamine agonists stimulate dopamine receptors in the brain, causing similar positive
effects as Levodopa without needing enzymatic conversion and its side effects. Even though
both of these methods are useful in alleviating PD symptoms, they are mainly used in the early
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stages of PD, as they are not as effective as Levodopa. Thus, most PD patients will have to take
Levodopa as part of their treatment [18, 19, 22, 21].
In addition to side effects such as nausea, vomiting, and hypotension, long-term intake of
Levodopa can cause motor impairments such as involuntary movements (dyskinesias), also
known as Levodopa-induced dyskinesia (LID) [23, 24]. Patients can exhibit LID after using
Levodopa for a few years, as they have to take increased doses of the medication due to worsening symptoms. Holloway et al. [25] observed the onset of such motor impairments in 74%
of PD patients within four years of starting Levodopa intake.
As PD symptoms worsen and Levodopa treatment loses its efficacy, clinicians opt to use
neurosurgical interventions to improve patients’ quality of life.

1.3.2

Deep Brain Stimulation

Deep Brain Stimulation (DBS) is the primary neurosurgical treatment for PD. In DBS surgery,
an electrode implant is permanently placed into the PD patient’s brain to deliver high-frequency
electrical pulses. The DBS electrode is then controlled with a pulse-maker placed subcutaneously in the chest (See Fig. 1.3(a)). DBS surgery is performed in later stages of PD after
the patient has started taking medication and can significantly help with motor symptoms of
PD such as bradykinesia and rigidity. DBS can also help with reducing the Levodopa dosage
patients need to take, which is especially important after patients start to experience side effects
of long-term use of pharmacological treatments [26, 27].
The DBS surgery itself is tailored to each patient based on MRI imaging of the brain and
can vary in the number of electrodes and their locations. DBS electrodes are generally targeted toward the STN and sometimes GPi, both components of the BG, which controls body
movements through dopamine [26]. Before the permanent insertions of the DBS electrodes,
intraoperative microelectrode recordings (MERs) are used to locate the targeted brain regions
(See Fig. 1.3(b)). Brain regions such as STN are small and located deep in the brain, making
the accurate placement of electrodes a challenging task. In a study of the outcomes of DBS
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(a)

(b)

Figure 1.3: (a) Illustration of a DBS device. (b) MER signals from different brain regions. It
can be seen that each region has a signature signal. Adapted from [2, 4].
surgeries, Okun et al. [28] observed that 46% of surgical and device-related complications were
due to sub-optimal electrode placement. This issue has led researchers to find ways to improve
the localization of brain regions, such as STN, to help surgeons in the placement of DBS electrodes. Data-driven and Machine Learning (ML) methods have been shown to address this
issue using MER signals [29, 30].

1.4

Electroencephalography

Neuroimaging methods such as EEG can be used in addition to UPDRS to monitor PD and the
effects of treatments on its progress. EEG is a non-invasive method in which several electrodes,
shaped as small discs, are placed on a patient’s scalp to monitor the brain’s electrical activity
over time. Besides neurodegenerative disorders such as PD, EEG is extensively used to study
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Alzheimer’s disease (AD), epilepsy, stroke, and sleep disorders [31, 32, 33, 34, 35].
EEG recordings can be conducted in different settings. In a resting-state EEG setting, data
can be recorded with the subjects seated, with eyes closed, and without performing any tasks
or moving their bodies. In a task-based setting, visual or auditory stimuli might be shown to
the subjects, and they can be asked to perform a cognitive or physical task, such as memorizing
a word or moving an object with their hands. The EEG device can also be time-locked to when
stimuli are shown and how tasks to progress to better study the changes in brain signals [36].
While clinicians have used raw recorded EEG signals to study brain disorders, many signal
processing methods exist to help researchers and clinicians alike analyze EEG data tailored
to their experiment designs and needs. Functional connectivity analysis is one such class of
methods that researchers use to study EEG data.

1.5

Functional Connectivity

Previous studies have shown that it is not possible to fully explain how specific brain functions are performed by studying brain regions in isolation. The brain is comprised of many
diverse regions that deeply interact with each other to perform various brain functions such
as memory and control. These regions, also called modules, work in a coordinated manner to
implement different cognitive processes. It has been suggested that these coordinated activities
can be studied through the analysis of neuronal oscillations. These oscillations can be recorded
through various modalities such as Magnetoencephalography (MEG), Functional magnetic resonance imaging (fMRI), and EEG. Then, the oscillatory synchrony of different brain modules
is studied, which reflects the flow of information between different modules. Functional Connectivity (FC) is then defined as studying pairs of brain signals from two distinct brain modules
by calculating how they interact through time. Results of FC can then be used to create large
networks of modules, all linked through their pairwise connectivity values. These networks
can then be used for whole-brain analyses [37, 38].

10
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Figure 1.4: PLI connectivity matrix of a PD patient extracted from lower α band data recorded
with a 32 channel EEG device. In this figure, each row and column is labeled with each EEG
electrode’s name. For example, the entry in the first row and the second column equals the PLI
connectivity value between EEG electrodes Fp1 and Fp2.
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One example of an FC measure is the Phase Lag Index (PLI). Given signal data from two
EEG channels, PLI computes the asymmetry of the distribution of instantaneous phase differences between pairs of channels, which is quantified as a number between zero and one [38].
Higher PLI values point to stronger connectivity, while lower values reflect weaker functional
connectivity between two channels. In a conventional FC study for an N electrode EEG, the
PLI values for all pairs of EEG channels are computed and stored in an N × N matrix (See Fig.
1.4). To fill out such connectivity matrices, a connectivity value between each pair of EEG
electrodes is needed. To this end, data from an N electrode EEG device are used, with one row
and one column assigned for each EEG electrode. If we assign an index to each electrode, the
PLI connectivity between the ith and the jth electrodes will be stored in the entry in the ith row
and the jth column of the matrix. Such matrices can be averaged across channels and subjects
or used to create graph and tree networks.
In connectivity studies, the full range of frequencies recorded by the EEG device is divided
into separate frequency bands before extracting connectivity values. This choice is made partly
since previous studies have shown that different frequency bands are associated with specific
biological and cognitive functions [39, 40, 41]. In our work, we look into five frequency bands:
δ (1-4 Hz), θ (4-8 Hz), lower α (8-10 Hz), upper α (10-13Hz), and β (13-30 Hz). This topic is
further discussed in Chapter 2.

1.6

Graphs and Trees: A Literature Review

In this thesis, we study the changes in global functional connectivity networks of PD patients
after taking Levodopa by studying their resting-state EEG data using graph and tree analysis.
In graph theory, we model networks using a series of nodes and links, where each link connects
two nodes and can have a weight, denoting how distant the two nodes are. A node is an EEG
electrode in our setting, while a link has a weight that signifies the connectivity strength of the
pair of nodes it connects. A variety of measures can then be introduced to analyze the whole

12

Chapter 1. Introduction

Figure 1.5: Basic components of a graph. Each blue circle is a node, while each black line is a
link connecting pairs of nodes. Each link can have a weight associated with it, signifying the
distance between a pair of nodes. The degree of a node is the sum of the weights of links that
come out of that node. Here, node B has a degree of 3, the sum of weights of links connecting
node B to nodes A and C. Adapted from [5].

network. All these metrics are discussed at length in Chapter 2. In this section, we will briefly
introduce graphs and trees and their application in studying brain disorders.
Two essential graph measures are “integration” and “segregation” of the network, telling
us how efficient or optimal a network is. Here, an optimal graph is balanced between two
extremes, random graphs with the highest integration and regular graphs with the highest segregation. Integration refers to how far nodes are from each other in the whole network. In an
integrated network, distances between different nodes are short, and the network is globally
efficient. Segregation tells us if the network consists of clusters of nodes, also known as hubs,
where nodes in a group are close to each other but far from nodes of other groups. It has been
shown that brain networks of healthy individuals have high levels of segregation and integration [42]. These networks are referred to as small-world networks, which are networks that
have a balance of high clustering, and short paths between pairs of nodes [42, 43].
More recently, minimum spanning trees (MSTs) have been used in graph analyses to address some of the shortcomings of using conventional graph theory metrics. Stam et al. [42]
reported that similar experiments using conventional graph methods tend to show contradictory
results when done by different groups. Conventional graph metrics can have bias and scalability issues, making it difficult to compare results in the literature. Differences in the number of
nodes, scaling, and thresholding of link weights can strongly affect the reported results, contributing to this problem. An MST of a graph includes every node and a subset of the links,
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such that moving through the link in one direction will not reach a node twice. Like smallworld graph networks, tree networks exist between two extreme forms: star and path trees. All
nodes except one are leaf nodes in a star tree, where a leaf node only has one link. In a path
tree, all nodes have two links except for two leaf nodes situated at the two ends of the tree (see
Fig. 1.6). Several metrics can be used to represent and compare different trees, as is done with
conventional graphs. We will discuss these metrics in Chapter 2 [42].

(a) Path tree

(b) Star tree

Figure 1.6: Two extremes of trees. In path-like trees such as 1.6(a), every node has exactly two
links except for two nodes that have only one, with these two called leaf nodes. In contrast,
star-like trees such as 1.6(b) have only one node that is not a leaf.

MSTs and graphs have been successfully used in several EEG studies to measure brain network changes between patients and control subjects in different neurological disorders. Gonzalez et al. [44] used MSTs to study differences between dyslexic children and those reading normally, finding that the brain networks of dyslexic children were less integrated when compared
to controls, based on significant changes in graph metrics in the θ band. Studying patients with
Mild Cognitive Disorder (MCI), Požar et al. [45] reported that MCI patients had significantly
lower functional connectivity and less integrated brain networks than healthy controls. They
also stated that using graph features alongside cognitive features and functional connectivity
measures improved the classification of MCI patients compared with classification having only
one set of features. Hatz et al. [40] used MST analysis to study apathy in PD patients, observing a correlation in the graph metrics of the upper α band with apathy scores. They also noted
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Figure 1.7: A diagram of a conventional EEG functional connectivity pipeline with graph
analysis

that apathetic PD patients had brain networks with lower segregation and higher integration.
Studying the effects of Levodopa on PD patients, Alonso-Frech et al. [46] recorded local
field potential (LFP) data from the subthalamic nucleus (STN) of PD patients off and on Levodopa. They reported a peak in the 10 − 30 Hz band that was reduced after Levodopa intake.
They also reported an association between 4 − 11 Hz oscillations and the expression of LID in
PD patients. Arroyave et al. [47] looked into differences in the resting-state EEG coherence of
PD patients, observing that PD patients had lower coherence in the upper α band than healthy
controls.
Yılmaz et al. [48] studied how α band EEG activity amplitude of PD patients correlated
with neuropsychometric tests, citing that the previous research had connected α band activity
to cognition. They observed that α activity amplitude was lower in PD patients vs. controls
and that α power decreased and test scores decreased in MCI and demented PD patients. They
specifically linked executive dysfunction to the low α activity of demented PD patients. In a
similar study, Geraedts et al. [49] linked a decrease in PLI connectivity in the upper α EEG of
PD patients with severity of PD.
Most relevant to our study, in a recent paper, Evangelisti et al. [50] evaluated combined
EEG/fMRI recording for studying Levodopa modulation of brain connectivity in PD patients.
Recruiting 8 PD patients (for two of whom they could not record the data), they recorded
resting-state eyes-closed data before and after taking Levodopa. For their EEG data, they
used a source localization technique that mapped electrode signals into 82 regions of interest
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(ROIs). They found no significant changes in EEG connectivity, though they reported significant changes in the fMRI setting. Their EEG results reported a non-significant trend toward
decreased functional connectivity for on vs. off Levodopa analysis in the ROIs of the motor
system for each frequency.

1.7

Thesis Objective

To the best of our knowledge, the work reported in this thesis is the first study to conduct
an EEG whole-brain network analysis of differences between PD patients off and on Levodopa
using MST and graph features extracted from PLI connectivity of resting-state EEG recordings
that have shown significant changes in these metrics. We hypothesize that MST and graph
network metrics can measure the effects of Levodopa on brain connectivity. These metrics
can also be linked to clinical changes due to Levodopa intake. Showing the effectiveness
of MST and graph methods in this problem can create an opportunity to understand better
how Levodopa works, which can help improve treatment for individual patients based on their
needs. Also, we only rely on EEG data and do not require MRI or fMRI imaging; This means
that if our method is validated, it can be a potentially cost-effective, portable, and non-invasive
clinical method to monitor the progression of PD and the efficacy of Levodopa.
The rest of this thesis is organized as follows: In the second chapter, we cover every step
of our pipeline, as shown in Fig.1.7. In this chapter, we define relevant concepts and provide
the theoretical background needed to understand each pipeline stage. We also discuss practical
considerations and the choices made in designing the pipeline. In Chapter 3, we present our
study design and the data we use and discuss the results we have obtained. We conclude the
thesis in Chapter 4, with a review of the contributions of the thesis and outlining the future
directions made possible by our study.

Chapter 2
Connectivity Pipeline: EEG Functional
Connectivity & Graph Analysis
2.1
2.1.1

EEG Connectivity
Pre-processing

In a typical EEG connectivity pipeline, we start with the raw data from electrodes, also known
as channels or sources. The first step is to pre-process the data, identifying artifacts and noise
from the signals and filtering or removing them. In this step, we can also segment the signals
into epochs by dividing them into smaller time units.
The first step in the pre-processing step is filtering our specific frequencies from the raw
data. One such filtering reduces the effect of power line noise interference on the data, which
can distort the signal at 50 or 60 Hz. A simple and common way to remove the line noise is
to use notch filters, but other methods such as EEGLab’s CleanLine have also been proposed
for better results [6]. Another type of filtering includes low-pass and high-pass filtering, which
we use to remove frequency data that is either normally noise or not required in our analysis.
The cutoff frequencies can differ, but based on our literature review, filtering frequencies lower
than 1 Hz and higher than 30 Hz is typical in the literature relevant to our work.
16
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After extracting the frequency information we need in our data, we can divide the signals
into different frequency bands. These frequency bands can include δ (1-4 Hz), θ (4-8 Hz), α
(8-13 Hz), and β (13-30 Hz) frequency bands. Specific frequency bands such as the α band
can also be divided into two smaller bands: lower α (8-10 Hz) and upper α (10-13Hz). One
reason for such partition of EEG data into separate frequency bands is the connections that have
been discovered between different frequency bands and biological and neurological functions.
For example, there is research connecting change in θ band activity in PD patients during a
cognitive control task [41]. Another example is the work of Abbasi et al. [39], which showed
in an MEG experiment that in PD patients, DBS stimulation reduces α and β band activity in
the cortex.
Another method used as the first step of the pre-processing is re-referencing the electrodes.
In EEG recordings, the voltage at each electrode is typically captured relative to a reference
electrode, though some devices can record data without a reference electrode. The common
reference electrode locations are the nose tip, one or both earlobes, and the Cz electrode (See
Fig. 2.1(b)). The choice of the reference electrode has been shown to cause a bias in the data by
changing the outcome of studies [51], which has led researchers to propose different methods of
re-referencing to improve the pre-processing of EEG data. Other than changing the reference
electrode, the common average reference and reference electrode standardization technique
(REST) are two alternative methods of re-referencing [6]. Common average referencing uses
the average of all electrodes as the reference, while REST standardizes the reference to a point
at infinity [52]. There is no consensus on which referencing method is the best, and each
method can be used based on the specifics of each study [53].
After re-referencing and filtering the data, artifact rejection is an essential part of the
pipeline. Both manual and automatic methods are available to perform both identification and
rejection of artifacts, all included in software packages such as EEGLab [6]. In manual artifact
rejection of EEGLab, the raw-time series data of all electrodes is displayed in a graphical interface, and we can remove noisy time spans from the whole signal (See Fig. 2.1(a)). In addition
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(b) EEG electrode locations

(a) Using EEGLab to identify artifacts and bad data
spans

Figure 2.1: In 2.1(a), we can observe EEG signals from a PD patient. The data span highlighted
in green has been identified as an artifact by EEGLab [6]. In 2.1(b), we can observe the
approximate location of each electrode on the scalp, projected to two dimensions.

to looking at the raw data, we can use Independent Component Analysis (ICA) [54] to isolate
noisy components due to ocular and muscular artifacts and remove them without removing
entire portions of the data from the original raw signal [55]. In this method, we use ICA decomposition to turn the electrode data into a number of statistically independent components.
Then, we can inspect each component and label and reject the ones that match different types
of noise typically found in EEG data. Finally, we convert the non-noise components back to
the electrode signals. Labeling ICA components does require expertise, and we can instead
use automatic techniques such as ICLabel [7], which classify components based on a dataset
of thousands of labelled recordings, an example of which can be seen in Fig. 2.2.
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After pre-processing our data, we can use a connectivity measure to find how pairs of
EEG channels synchronize. Next, we will describe a few such metrics, comparing them and
choosing one for our analysis.

(a) Noisy ICA components

(b) Brain ICA components

Figure 2.2: Results of using ICLabel [7] to classify ICA components. In 2.2(a) we can see
three components that have been classified as noisy components. We can see that in the eye
components, electrodes near the eyes of the subject are highly active. This is not the case in
2.2(b).

2.1.2

Extracting Connectivity Values

After pre-processing, we need to extract connectivity values for each electrode. Several connectivity measures are designed to extract both frequency-domain and time-frequency-domain
connectivities from EEG data, with PLI and phase Coherence (COH) being two of these measures [38]. Suppose we have an EEG device with N electrodes. For any given electrode, a
connectivity measure gives a vector of N quantitative values to represent the connectivity between that electrode and every electrode, including itself. We can store these vectors as N × N
matrices, one for each epoch. We can also average these matrices across epochs into a single
matrix. After creating such matrices, we can finally use statistical methods appropriate for
our experiment design to observe how electrodes interact and how these interactions change
through time, and the interventions we might make. These methods can range from simple
statistical tests that check if connectivity matrices change to methods such as graph analysis,
which we use, to create a new network model from the connectivity matrices.
As we mentioned in the introduction, connectivity analysis or FC aims to find the statistical
interdependencies between time series. No matter which neuroimaging method we use, the
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FC metric we choose should address a primary issue with studying synchrony of time series,
which Stam et al. [38] called the problem of common sources. As they explain, this problem
can manifest in two different ways: volume conduction and active reference electrode. When
recording neuroimaging data, a fundamental problem is our inability to identify a unique mapping between data recorded by the sensors (electrodes) and the underlying neuronal activity,
also referred to as active sources. Nearby sensors will inevitably include in their recorded data
activity from common sources. We will find spurious correlations if we run statistical methods
on time series data from a pair of such sensors. This is the problem known as volume conduction. The active reference electrode problem is related to volume conduction and unique to
EEG, which causes signals recorded from every other electrode to include similar components.
Stam et al. [38] then proposed PLI as an FC metric that is invariant against the problem
of common sources. They designed PLI with the hypothesis that given two time series, a
consistent and non-zero phase lag δφ between them cannot be caused by volume conduction
coming from a single strong source. Such a phase lag is then thought to give an accurate
estimate of how the underlying sources interact. PLI is then defined as the asymmetry of the
distribution of instantaneous phase differences between two time series. In this definition,
phase difference asymmetry means that the likelihood of −π < δφ < 0 is different from the
likelihood of 0 < δφ < π. Also, the instantaneous phase of signals is computed using the
analytical signal based on the Hilbert transform. Given time series xi (t) and x j (t) and their
instantaneous phases φi (t) and φ j (t) for t = 1 . . . m, and the sign function sgn, their PLI value
is:
m

PLI i, j

1X
sgn(φi (t) − φ j (t))|
=|
m t=1

(2.1)

By this definition, PLI i, j is between zero and one. PLI i, j = 0 means that the two time
series are either not coupled or are coupled with a phase difference centred around 0 mod π.
PLI i, j = 1 means that the two time series have a perfect phase locking value of δφ which is
different from 0 mod π. So larger PLI values indicate stronger connectivity.
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Stam et al. [38] compared the performance of PLI with other widely used FC metrics,
such as phase coherence (COH) and the imaginary part of coherence (ICOH). They tested
the performance of these three metrics on simulation and real-world data, including EEG data
of groups of AD patients and healthy controls, EEG seizure data, and MEG data recorded
from two healthy subjects. They observed that compared to COH and ICOH, PLI performed
equally well in detecting true changes in signal synchronizations and was less affected by
volume conduction and active reference electrodes. Following these results, Hardmeier et al.
[56] reported that PLI was a reliable FC metric in longitudinal studies, further validating PLI’s
efficacy. Since its introduction, PLI has been extensively used in connectivity analyses. The
graph theory EEG studies that we covered in our literature review in Chapter 1 all used PLI as
their FC metric.

2.2
2.2.1

Introduction to Graph Theory
Definition of a Graph

In graph theory, a graph or network is modelled with nodes and links. Each link has two
endpoints in a graph, referring to the two nodes that the link connects. Two nodes that are
connected by a link are called neighbours. A link can have both a direction and a weight
associated with it, though we mostly focus on undirected graphs. Given a weighted graph, a
node’s degree is defined as the sum of the weights of the links connected to that node. If the
graph is not weighted, the degree then equals the number of the neighbours the node has. In
graph theory texts, weights are usually defined by Euclidean distances so that a link weight
establishes the distance between two nodes. But, as we will see later in this chapter, these
weights can also be defined in other ways [5].
Another important term in graph theory is the path, defined as a series of links that connect
a set of distinct (non-repeated) nodes. A path has a starting node and an end node. Cycles
(loops) are then defined as a series of links where the only repeating nodes are the start and end
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Figure 2.3: Overview of graph measures. Similar to 1.5, dots are nodes, and black lines are
links in a graph. The degree of the red node in the middle graph is three, as it is connected to
three nodes. In the clustering graph, we can see a group of nodes with multiple links to each
other. In the shortest path graph, there are two main paths between the red and green nodes.
One passes through nodes A, B, and C, while the other only passes node C. The latter one is
the shortest path, which is also unique in this graph. Adapted from [5].
nodes, both referring to a single node. The length of a path or cycle is defined as the sum of
the links weights in that path. The shortest path between a pair of nodes then refers to the path
with the smallest possible length that connects the two nodes.
Continuing on the concept of paths, we say a graph is connected when we can start from
any node and follow a path to any other node. If a graph is not connected, it can be partitioned
into connected subgraphs, known as connected components. To find a connected component,
we can start with a node and try all possible paths, recording every node we visit. When all
paths are exhausted, the set of the visited nodes and the original node we started from form a
connected component.
Now that we have covered the basic concepts in graph theory, we can introduce “Smallworld graphs”.

2.2.2

Small-World Networks

Graphs and other forms of network analysis have long been used to model and study a variety
of social, biological, and technological systems. Social media, the gene regulatory system,
the power grid, and the organization of neurons in the brain are only a few examples of such
phenomena. In their seminal paper, Watts and Strogatz [8] noted that while most network anal-
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yses at the time were modelled as either regular or random networks, many networks seemed
to occupy a place between these two networks. To better study such systems, they proposed
the small-world networks and showed that multiple social and biological networks have hallmarks of a small-world network. To introduce what small-world networks are, we will begin
by defining regular and random graphs.
In graph theory, a graph is said to be regular if every node has links to the same number
of nodes. If in a graph each node has k links, we say that the graph is k-regular. In contrast,
a random graph is not defined by a single scalar k but by a probability distribution, where the
existence of a specific link is mapped to a probability value. To find the intermediate model
between these two extreme cases, Watts and Strogatz proposed the following procedure. First,
they started with a k-regular graph and then rewired links to different nodes randomly with
probability ρ. With ρ = 0 we are left with the same regular graph we started, and with ρ = 1
every link is rewired, giving us a random graph. Graphs between regular and random graphs
can then be created by following this procedure with 0 < ρ < 1. To quantify such networks,
they introduced two metrics: characteristic path length (CPL), which equals the average of all
shortest paths between all pairs of nodes, and clustering coefficient (CC), which for a node
is defined as the fraction of the number of links between neighbours of a given node to the
maximum possible number of such links.
CC is a measure of local connectivity of a network, with higher CC values pointing toward a more segregated network with higher local specialization. CPL can then be seen as
a measure of global integration, with lower CPL values showing a network with a high level
of integration, where information can be easily moved from one node to another. In regular
graphs, CC and CPL are both high, while both metrics have smaller values in random networks.
Watts and Strogatz observed that as they slowly increased the probability ρ in their procedure,
creating graphs that are more random than regular, CPL values quickly fell while CC values
barely decreased. They named such networks where CC is high and CPL low as small-world
networks. Then, they studied multiple real networks, including the neural network of the C.
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(a) ρ = 0

(b) ρ = 0.5

(c) ρ = 1

Figure 2.4: Visualizing the procedure of Watts and Strogatz [8] procedure for creating smallworld and random graphs from regular ones. In each case, the procedure starts with a regular
graph such as the one in (a) and starts randomly rewiring links with probability ρ. We can see
that with larger values of ρ, the procedure’s output is more similar to a random graph. Adapted
from [8].

elegan worms, the power grid of the United States, and the network of film actors and observed
that all these networks have characteristics of a small-world network.

As a result of this paper [8], many other networks were found to possess small-world features. In the case of brain networks, studies of simulated neural networks showed the optimality of small-world networks in information processing. Furthermore, in-vivo brain studies of
healthy human subjects through imaging techniques such as fMRI, MEG, and MEG showed
that their brains do indeed show small-world characteristics. A natural continuation of this line
of research was to study how small-world network metrics change in brain disorders, such as
AD and PD.

2.2. Introduction to Graph Theory

2.2.3

25

Brain Network Analysis with Small-World Graphs: A literature
Review

Since the introduction of small-world networks, they have become a valuable tool in studying a
range of economics, biology, and technology systems. Most relevant to our work, these methods have also been extensively used to investigate the human brain’s structural and functional
behaviour, both in healthy people and those dealing with different neurological disorders. Here,
we will review some of the relevant results and then discuss the shortcomings of conventional
graph methods that necessitate the use of trees.
Following the work of Watts and Strogatz [8], researchers conducted many experiments
using different modalities such as EEG, MEG, and fMRI to see if human brain networks possess the hallmarks of small-world networks. The consensus of this line of research was that
brain networks of healthy human subjects have high levels of clustering in their nodes, with the
average shortest path between the nodes being small. These results validate the hypothesis that
brain networks can be effectively modelled as small-world networks. Furthermore, research
into the degree distribution of these networks has shown the existence of a large number of hub
nodes that account for many links in the graph. Moreover, these hubs are also deeply connected
with one another. Both of these results tell us that these networks can also be characterized as
small-world.
Following the successful modelling of brain networks of healthy adults as small-world, the
study of these networks through time, during both development of the brain during growth
and its degeneration due to illness, became an essential step in using network modelling for
analysis of the brain. Analyzing brain networks of children from a resting-state eyes-closed
EEG experiment collected twice at ages 5 and 7, Boersma et al. [57] observed that as their
subjects grew, the average clustering of their EEG graph networks increased. In contrast, the
average shortest paths decreased, with these results being observed mainly in the α and β
bands. Using these results, Boersma et al. concluded that brain networks shift from random
graphs to small-world ones as children’s brains mature. Studying a cohort of twins and their
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siblings, again using resting-state eyes-closed EEG, Schutte et al. [58] observed that smallworld metrics CC and CPL are both heritable traits, linking their variance to genetic factors.
Studying neurodegeneration has also been another fruitful application of small-world networks. In the first investigation of this topic, Stam et al. [59] recorded a resting-state EEG
experiment from a group of AD patients and a group of healthy controls. Then, they extracted
CC and CPL values for each subject from their β band EEG recordings and compared the group
differences. They found that while networks in both groups have small-world characteristics
compared to random graphs, the AD group had significantly larger CPL values, pointing toward less integrated networks than healthy subjects. They also studied the correlation between
small-world metrics and subjects’ scores in the mini mental state examination (MMSE) test.
MMSE is a test routinely used by clinicians to diagnose dementia. In this test, the clinician
fills out a questionnaire, awarding points to different cognitive abilities such as recall or orientation to space, with higher values corresponding to higher cognitive skills. In their study,
Stam et al. [59] reported that higher MMSE scores were correlated with higher CC and lower
CPL values. Connectivity analysis using CC and CPL has also been found to be effective in
differentiating between patients and healthy controls for several other disorders, including apathy in PD patients [40], major depression disorder [60], and mild cognitive impairment [45].
Similar to the work of Stam et al. [59], these studies have shown that small-world metrics
significantly change as patients’ brains degenerate. Additionally, these metrics correlate with
different clinical examinations used to evaluate cognitive decline in each disorder.

2.2.4

Shortcomings of Conventional Graph Analysis

Despite the successes in using small-world graphs for analyzing brain networks, researchers realized that similar studies of identical disorders led to significant but contradictory results. This
issue motivated researchers to investigate the causes of these conflicting results and introduce
minimum spanning tree methods as an unbiased tool that can help us compare research results
across different disorders and experimental conditions [42]. Next, we will review problems
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with small-world metrics and then introduce tree methods in the next section.
One crucial hypothesis in the graph-based analysis of brain networks is that if brain graphs
created from studying the same condition using different neuroimaging techniques capture the
same underlying brain connectivity network, the topological features of these graphs should
match [61]. Tijms et al. [61] conducted a comprehensive review of research on AD using
graph theory analysis to investigate this hypothesis. Their study showed a notable variance
in results across different studies, which they considered evidence that brain graphs are not
comparable in different modalities. They noted that in the papers they reviewed, some reported
a significant increase in the clustering coefficient of brain graphs in AD patients compared to
healthy controls, while some reported a significant decrease, and a few reported no significant
change. Tijms et al. [61] observed that similar conflicting results were reported for the characteristic path length as well. Reviewing problems with graph methods and proposing MST
methods as an alternative, Stam et al. [42] wrote that this variance was not unique to studies of
AD that Tijms et al. [61] had reviewed and was also evident in graph analysis of other brain
diseases such as epilepsy. To better understand the underlying issues with graph methods, they
offered an example which we will discuss next.
As we mentioned in the discussion on connectivity pipelines, the end result of such pipelines
is an N ×N matrix where the entry in the ith row and jth column holds the connectivity between
the ith node and the jth node, where nodes can be EEG electrodes and connectivity values are
PLI values. A method often used to create brain graphs from these matrices is to threshold
connectivity values with a value T . In an EEG setting, we start with an empty graph with the
N EEG electrodes as nodes, then choose connectivity values greater than or equal to T and add
a link to the graph between the pair of nodes corresponding to the ith and jth electrodes. We
denote the number of links that are added to the final graph as m. The resultant graph is then
called a binary graph, where links do not have a weight, so pairs of electrodes are either linked
or not.
Now, let us assume we are given two graphs G1 and G2 , created by the procedure we de-
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scribed. These graphs have the same N and T , and we are supposed to compare their topology.
Two issues make the comparison problematic. First, given equal T and N, there is no reason to
assume that the number of links, m, will be the same. Different values of m in G1 and G2 can
change the values of the clustering coefficient and characteristic path length, as a larger number
of links will decrease CPL and increase CC, up to the point where all nodes are linked, and the
average CC and CPL are both equal to one. Furthermore, there is no agreed-upon method to
choose T in the literature, which is practically chosen arbitrarily. Some researchers proposed
using ranges of T to create graphs, but this solution fails as well, since these ranges are also arbitrarily chosen. Running the pipeline on multiple T values can also cause more false positives
if not properly corrected for multiple comparisons.
Researchers have come up with solutions such as fixing the value of m and choosing the
value of T or normalizing values of CC and CPL by creating random graphs from the original graphs, similar to the procedure used by Watts and Strogatz [8]. While these solutions
solve some of the bias problems, they also introduce new biases. In the first solution, fixing m
changes the problem of choosing the right T to choose the right m, which has the same problems as before. In the second case, the choice of the right m remains, and research by van Wijk
et al. [62] has shown that normalization with random graphs does not entirely solve the bias
problems. Stam et al. [42] show that these issues persist even by changing the graph creation
procedure not to use thresholding or keeping the weights of selected links after thresholding.
Due to these issues, van Wijk et al. [62] and Stam et al. [42] offered MSTs as a solution, which
we will introduce next.
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Minimum Spanning Trees
Definition of a Tree

A tree is a connected graph that does not have any cycles. Based on this definition, a tree
with N nodes has exactly m = N − 1 graphs, as the minimum number of links required to
connect N nodes is N − 1. Adding any extra links would create a cycle as the new link has to
connect two nodes that are already connected. A spanning tree for a graph is then defined as a
subgraph with no cycles, where all the nodes in the original graph are included and reachable.
There can be several such trees for any given graph, and the spanning tree where the sum of the
included links in the tree are minimized is called a Minimum Spanning Tree, or MST. There
are multiple algorithms for creating an MST from a graph, such as Kruskal’s algorithm [63]
or Prim’s algorithm [64]. We will cover the former in section 2.3.3. An important property of
MSTs is that if all the link weights of the original graph are unique, the MST will be unique
as well. This becomes an important reason to use them to address the issues we discussed with
conventional graph methods [42].

2.3.2

Advantages of MSTs Over Conventional Graphs Methods

Using MSTs has a number of advantages compared to graphs created directly from raw data.
First is how MSTs are a simplified version of the original graph, where the most critical connections are kept, and the rest are filtered out [42]. To have fast network analysis algorithms,
we have to deal with a polynomial number of links compared to the number of nodes (O(N 2 ))
with graphs, where the number of links in trees is linear with the number of nodes (O(N)).
In addition to this, using MSTs has specific advantages for the problem of studying brain networks.
As we mentioned in section 2.2.4, the main issue with using small-world networks is the
lack of a proper way to compare different networks. This issue is caused by the arbitrary
choice of the thresholding value T and the variable number of links m in the binary graph

30

Chapter 2. Connectivity Pipeline: EEG Functional Connectivity & Graph Analysis

created by thresholding. As mentioned, an MST will be unique if the weights of the original
graph are unique. In a hypothetical EEG analysis, this means that if we create MSTs on two
datasets with the same N electrode EEG device, we will be left with two MSTs with the same
number of nodes and links (An MST has N − 1 links). Also, in creating an MST, the same
measure, the minimum weight is used to choose the links in both cases, so there is no need for
an arbitrarily chosen T . The chosen links in the MSTs also do not have weights, so we do not
need to worry about different connectivity weight distributions in different conditions biasing
our results [5, 42].
Thus, using MSTs solves the problems we have with small-world graphs by giving us
comparable and unique trees, where variables such as the number of nodes and links, the link
selection criteria, and weight distribution are all accounted for and controlled. However, using
trees is not without its disadvantages. As Stam et al. [42] state, after discussing the advantages
of MSTs we just covered, we are still losing valuable information about the networks by not
keeping link weights. This is particularly important for studying clusters, which are no longer
possible when we do not keep the cycles in the original graphs to create MSTs. The tree metrics
that we will define later in the chapter have been shown to capture some of that information.
We will now show how MSTs are actually created.
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Kruskal’s Algorithm

The primary algorithm used in the literature to create MSTs from connectivity graphs is Kruskal’s
algorithm. In its most general form, the algorithm starts with an empty graph with the vertices
of the original and keeps adding the link with the smallest weight such that the new graph remains a tree [63]. It can then be proved that the resulting graph is both spanning and minimum
weight, so it is an MST. The detailed algorithm is given below.
Algorithm 1: Kruskal’s Algorithm: The generalized version
input : Graph G with sets of vertices and weighted links VG and EG , respectively
output: Minimum spanning tree T = (VT , ET )
1 S ← ET
2 VT ← VG
3 ET ← ∅
4 T ← (VT , E T )
5 while T is not a spanning tree do
6
e ←The link with the smallest weight in S
7
Remove e from S
8
if Adding e to ET does not form a cycle then
9
Add e to ET
10
end
11 end

The most efficient way to implement Kruskal’s algorithm is to use the Disjoint-set data
structure, also known as the Union-Find data structure [65]. In a Union-Find data structure,
we have groups of sets, such that no pairs of sets share any member. Similar to a conventional
set, we can also define the union of sets with similar results. The primary functions defined for
Union-Find sets are: MakeSet creates a set, Union merges two sets, and Find returns the set to
which a set member belongs [66].
In this version of the algorithm, we start by initializing each graph node as a disjoint set.
Then, each time the smallest link is chosen, we check if the two vertices that will get linked by
this link belong to different sets. If so, we add the chosen link to the new graph and replace the
two corresponding sets with their union. Otherwise, adding that link will form a cycle, as all
vertices in a set are already connected. The pseudo-code for this algorithm is given below.
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Algorithm 2: Kruskal’s Algorithm: Union-Find data structure
input : Graph G with sets of vertices and weighted links VG and EG , respectively
output: Minimum spanning tree T = (VT , ET )
1 VT ← VG
2 ET ← ∅
3 T ← (VT , E T )
4 foreach node v in VG do MakeSet(v)
5 link queue ←Edges in EG sorted by their weights in increasing order
6 while link queue is not empty do
7
(v1 , v2 ) ←Remove the link from the front of link queue
8
if Find(v1 ) and Find(v2 ) are different sets then
9
Add the link e = (v1 , v2 ) to ET
10
end
11 end

In an MST, the weight of an link is defined as the distance between two vertices, so the
smaller the weight, the closer the vertices are. But this is not always the case in EEG connectivity analysis. For example, a PLI value ranges between zero and one, with higher values
corresponding to stronger connectivity between a pair of nodes. Thus, larger weights mean that
two nodes are closer. Reviewing the literature, researchers usually replace the PLI connectivity
matrix with a new one. In this new matrix, each entry is computed as either the inverse of
the original value or the result of subtracting one from it. It should be noted that given such
weights, we can redefine MST as the maximum spanning tree, in which the sum of the weights
is maximized. The maximum spanning trees are well defined in graph theory, similar to the
minimum spanning trees. Kruskal’s algorithm can be created by sorting the links in decreasing
order and choosing the link with the largest weight instead of the smallest one. This way, there
is no need to transform the PLI connectivity matrix. Finally, the weights of the links in the
MST resulting from running Kruskal’s algorithm are all set to one, similar to the binarization
done in conventional graph methods (See Fig. 2.5) [42, 40, 45].
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(a) PLI connectivity matrix

(c) MST
(b) MST adjacency matrix

Figure 2.5: Visualization of the EEG connectivity pipeline from forming a PLI connectivity
matrix to creating an MST network. For illustration, extracted lower α band resting-state EEG
data from a single PD patient was used. First, the PLI matrix (a), created similarly to 1.4, is
computed by averaging PLI matrices of PD patients from a resting-state EEG dataset. Then, the
adjacency matrix (b) of the MST is generated by running Kruskal’s algorithm on (a). Lastly,
the MST in (b) is drawn as a graph in (c) with EEG electrodes as nodes and non-zero PLI
values as links. The links in MSTs do not have variable weights, which is why entries in the
MST adjacency matrix (b) are either zero or one.
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2.3.4

Stars and Paths: Tree Metrics

Similar to small-world graphs, trees exist between two extremes; star trees and path trees. As
we first stated in Section 1.6, star trees are made up of N − 1 nodes with a single link, known
as leaf nodes, and a single node linked to every other node. In contrast, there are only two
leaf nodes in path graphs, while the other N − 2 nodes have two links each. Following the
comparison with small-world graphs, we can use several metrics to quantify how much any
given tree is star-like or path-like [42].
The first tree metric is the diameter (DM). The diameter of a tree is the distance of the
longest path between any pairs of nodes in the tree. In a star tree, each node is at most two
links away from any other node. In a path tree, the longest path is the one that has the two
leaf nodes, which is N − 1 links long. So, a larger DM points toward a more path-like tree,
while a tree with a small DM is more star-like. DM has a similar interpretation as the CPL in
small-world networks, meaning that diameter is a measure of the integration of the network.
With a small diameter, the network is more globally efficient.
The second metric of note is eccentricity (ECC), which for each node is defined as the
longest path from that node to any other node in the tree. We can use the average of every
node’s ECC to compare different trees. As the definition suggests, ECC is directly linked to
DM, with DM being the maximum eccentricity in the tree. The meaning of ECC is also similar
to what DM means. As a practical note, eccentricities are calculated from the shortest paths of
the tree, so the ECC of a tree node v is equal to the largest shortest path from v to any other
node in the tree.
Leaf fraction (LF) is another important metric in MST analysis. LF equals the fraction of
the number of leaves in the tree to the number of nodes N. LF at maximum equals to

N−1
N

in

star trees and is at minimum in path trees with the value of N2 .
A few of the metrics used for MST analysis are all derived from the concept of centrality,
which is defined in complex network analysis in various ways. We will cover two of these here:
Degree Centrality (DC) and Betweenness Centrality (BC).
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As explained in our introduction to graphs, the degree of a specific node in an unweighted
graph refers to the number of links that node has. In a weighted graph, the degree of a node
becomes the sum of all links connected to that node. DC then defines a node as central if it has
many links to other nodes. In a tree, the largest possible DC occurs in a star tree, where the
singular non-leaf node is linked to every other node in the tree. Another definition for centrality
is BC. In BC, a node has high centrality if many paths have to pass through it. To compute
the BC of a tree node v, we first find the shortest paths between any pairs of nodes. Then,
we find the number of shortest paths that pass through v. Then, BC equals the fraction of the
number of shortest paths passing v to the total number of shortest paths. Again, the node with
the highest BC is the non-leaf node in star trees, where every path between leaf nodes has to
pass the non-leaf node. To compare different MSTs, we can use the average or the maximum
of BC taken over every node of an MST.
BC and LF are used in a crucial metric in MST theory, Tree Hierarchy (TH). The formula
for TH is:

TH =

Number of leaves
2(N − 1) max(BC)

(2.2)

where max(BC) is the maximum betweenness centrality taken over all nodes in the tree. The
idea behind TH is to define an intermediate network between star and path trees, similar to
how small-world networks are an intermediate topology between regular and random graphs.
In this intermediate tree, nodes are not very far from each other (relatively high number of
leaves), while no single node has such high centrality that every path has to pass through it.

2.3.5

Connectivity Analysis with Trees: Literature Review

Reviewing the literature on using MSTs in network analyses, a similar body of research can
be found that validates the use of MSTs in brain network research, some of which we already
covered in 1.6. Theoretical studies in fields such as market modelling in economics, commu-
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DM
avgECC
LF
maxBC
TH

Intervention
Pre
Post
0.4285 0.7142
0.3928 0.6071
0.75
0.5
0.9523 0.7142
0.45
0.40

(c) Tree Metric Change
(a) Pre-Intervention Tree

(b) Post-Intervention Tree

Figure 2.6: Visualization of changes in tree metrics after an intervention. Here, we have a
simulated tree with eight nodes. As can be seen in 2.6(a), the original tree has a long path
component stretching from node 1 to 8 and a star-like component centred around the central
node 7. Our intervention removes two leaf nodes from the star component and adds them
to the path component. Specifically, we remove node 3’s link to node 7 and instead connect
it to nodes 2 and 4. The resulting tree is shown in 2.6(b). In the table in 2.6(c), we have
computed the MST metrics introduced in Section 2.3.4 both before and after the intervention.
avgECC is the average ECC of all nodes, and maxBC is the maximum BC over all nodes. We
can see that these metrics capture different effects of the intervention. Adding nodes to the
path component increases DM and avgECC. Removing leaf nodes results in lower values for
LF and TH. Making the central node 7 less star-like by removing its leaves results in a lower
maxBC in the tree, affecting the value of TH.
nication networks, and protein interactions [67, 68, 69] revealed that MSTs indeed capture the
essential information from the data and help with the study of many different problems. In a
study of transport in weighted networks, Wu et al. [70] observed that MSTs could be partitioned into two subnetworks: superhighways and roads. Superhighways refer to tree components with high centrality nodes, while roads include nodes with lower centrality. They found
out that small perturbations in the superhighways caused large disruptions in the global transport of the network, which was considerably less when done for road nodes. Their conclusion
validated the importance of centrality as a metric for quantifying changes in the trees.
Searching for experimental studies that used MSTs to analyze brain graphs, we observe
that MSTs have been successfully used to study various neurological disorders across different
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neuroimaging modalities. In an EEG study of epileptic patients, Lee et al. [71] reported that
using a dissimilarity measure for MSTs based on entropy, they could differentiate between
patients with left temporal lobe epilepsy (LTLE) and right temporal lobe epilepsy (RTLE) in
the seconds preceding seizure onset. They found that LTLE and RTLE patients’ MSTs differed
significantly, showing the re-organization of the brain networks, even though their connectivity
matrices did not.
Following their small-world study of brain network differences in children at 5 and 7 years
of age, Boersma et al. [72] used resting-state EEG data of 227 children recorded once at five
years old and a second time at seven years old. Their results showed that the DM and ECC
rose as the subjects grew, while LF and TH were reduced in the α band. This indicates that the
brain networks became more path-like as time passed. Comparing the small-world and MST
studies of Boersma et al. [57, 72], changes in CC and CPL seem to correspond with changes
in DM and LF. Commenting on this comparison, Stam et al .[42] argue that we can also link a
shift toward a more regular network to a transition toward a path-like tree. This further shows
that MSTs are capturing the information we could get from small-world metrics without their
downsides.

2.4

Conclusion

This chapter reviewed different parts of the pipeline for graph analysis of EEG data, starting
from a theoretical background to practical considerations. We discussed graphs and trees at
length, explaining their definitions and interpretations, and concluded by describing work in
the field. Having shown the validity of the underlying methods we have chosen to use, in the
next chapter, we discuss the experiments and results we obtained on the effects of Levodopa
on the brain networks of PD patients.

Chapter 3
Graph Network Modulation of Levodopa
in Parkinson’s Patients
3.1

Introduction

By implementing the EEG pipeline described in the previous chapter and using Graph theory
methods, we set out to study how Levodopa affects the brain network of PD patients in a
resting-state EEG setting. In this chapter, we describe our methods and the specific choices we
made for our pipeline. Then, after reporting the results, we perform a detailed analysis.

3.2
3.2.1

Methods and Materials
Subjects

For this study, 16 PD patients (7 female and 9 male, Age = 68 ± 6 years; years diagnosed with
PD = 8 ± 6 years, and daily Levodopa dose of 929 ± 412mg) were recruited. All subjects
signed informed consent before recording, and the study was approved the Research Ethics
Board of the University of Western Ontario (HSREB file number 107253, see Appendix A).
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EEG Recording and Preprocessing

Resting-state EEG data was recorded using a 32-channel EEG device with a sampling rate of
250 Hz. In each session, subjects sat with their eyes closed as the EEG signal was recorded
for five minutes. Two recordings were performed on the same day for each patient. First, an
EEG recording was done after each subject had been off Levodopa for 12 hours or more, and
the second one was done one hour after the patient took their prescribed dosage of Levodopa.
Each EEG recording was preprocessed offline, starting with re-referencing the EEG data
using the average reference, followed by low and high pass filtering of the data at 1 Hz and 30
Hz. Then, time spans with excessive noise and artifacts were removed, and ICA was used to inspect each recording, removing independent components due to ocular and muscular artifacts,
and transform the data back to electrode signals. Finally, the method proposed by Fraschini
et al. [73] was used to find the optimal epoch length, which was set to 8 seconds. All of the
preceding steps were performed in MATLAB [74] using the EEGLab toolbox [6].

3.3

Functional Connectivity

Phased Lag Index (PLI) [38] was used to study the connectivity of EEG channels, which computes the asymmetry of the distribution of instantaneous phase differences between every two
signals rejecting the common source artifacts. Two signals can have a PLI value between zero
and one, with larger values showing higher connectivity between the two signals.
In each recording, PLI values of every pair of electrodes were computed per epoch for
frequency bands δ, θ, lower α, upper α, and β, averaging the results over epochs to find the
average PLI connectivity. The results consist of five 32 × 32 PLI connectivity matrices for each
recording, one for every frequency band.
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Constructing Graphs and Trees

Based on our discussion of FC in Section 2.3, in the connectivity graphs that we study, each
node refers to a specific EEG electrode, and each link and its weight signify the connectivity
strength between the two nodes the link connects. Here, a pair of highly connected nodes
have a lower distance, represented by a smaller link weight. As larger PLI values point to
stronger connectivity between pairs of nodes, each value in the PLI connectivity matrices was
subtracted from 1, and the resulting values were then used to create adjacency matrices, where
nodes with higher connectivity values have smaller weights. Then, the Kruskal algorithm [63]
was run on each adjacency matrix to find the corresponding MST. As mentioned in Chapter 2,
the Kruskal algorithm starts with an empty graph with the nodes of the original graph and adds
the minimum weight links until a tree is formed. As the final step, the resultant MSTs were
binarized by setting the weight of all MST links to one.

Table 3.1: Description of network metrics. These metrics were discussed in detail in Section
2.3.4.
Symbol
DG
maxDG

Name
Degree
Maximum degree

DM

Diameter

ECC

Eccentricity

avgECC

Average Eccentricity

LF

Leaf fraction

BC

Betweenness centrality
Maximum Betweenness
Centrality

maxBC
TH

Tree hierarchy

Definition
Number of links a node has
Largest degree of all nodes in the tree
Longest distance between
any pair of nodes in the tree
The length of the longest path
from one node to any other node.
Average Eccentricity across
all nodes of the tree
Fraction of the number of leaves to
the number of nodes
Fraction of all paths containing a node
Largest between centrality
of all nodes in the tree
Fraction of the number of leaves to
(2 × the number of links × maxBC)
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Network Metrics

The following network metrics were extracted from each MST adjacency graph to characterize
connectivity networks: maxDG, DM, avgECC, LF, TH, and BC [75, 42]. A short description of
each metric is given in Table. 3.1. As we have discussed, MSTs have been shown to be useful in
differentiating patients and healthy controls in brain disorders such as dyslexia, Amyotrophic
Lateral Sclerosis (ALS), and AD [44, 76, 75, 45].

3.6

Statistical Analysis

The study’s main goal was to see if taking Levodopa significantly changes the brain networks
of PD patients when measured by MST metrics. To this end, we needed to analyze each metric
to see if its values in the subject population changed significantly or not. This analysis also has
to be done over different frequency bands to see if specific frequencies are affected.
First, the Shapiro–Wilk [77] test was used to test if the distribution of metric values were
normal or not. The result showed that they were not. Then, the Wilcoxon signed-rank test [78]
was used for each metric in each frequency band to test if any metric had significantly changed
after the patients took Levodopa.
The Wilcoxon signed-rank test is a non-parametric statistical hypothesis test. For a variable
of interest, the signed-rank test can be used to test whether the paired measurements from two
populations significantly change or not. The signed-rank test is suited for dependent or paired
samples, where one group is measured twice, which is the case in our study. In this regard,
the Wilcoxon signed-rank is similar to the paired Student t-test, but without the assumption
that samples are normally distributed. This study used a two-sided Wilcoxon signed-rank test
with the null hypothesis that given paired samples x and y, x − y has a distribution with a zero
median [78]. The significance threshold was set at 0.05 and corrected for multiple comparisons
using a false discovery rate (FDR) [79]. We similarly tested for changes in PLI connectivity in
each frequency band by taking each subject’s average PLI and testing its changes on and off
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Levodopa.
Multiple comparisons problems arise when a large number of statistical tests are performed
simultaneously, which leads to a high probability of seeing false positives. Consider a case
where we have measured 100 variables from two groups. We want to perform hypothesis
testing with a significance cut-off of 0.05 to see if these variables are significantly different
between the two groups. This means that if we test a single variable, the probability of rejecting
the null hypothesis when it is true is 5%. However, if we test for 100 independent variables,
the probability of seeing at least one false positive is 100 × (1 − 0.95100 ) ≈ 99.4%. Several
correction methods have been proposed to address this issue and control for false positives,
including FDR. In the Benjamini–Hochberg procedure for FDR, designed for m independent
tests with significance cut-off at α, p-values are sorted first. Then, the kth p-value, which is less
than or equal to mk α, is computed. Lastly, the first k null hypotheses are rejected, meaning that
the corresponding variables have significantly changed [79].
Another critical question was whether changes in UPDRS scores and changes in metric
values were correlated after Levodopa intake. As Levodopa alleviates various PD symptoms,
the UPDRS scores of PD patients are decreased after taking the medication. Finding a link
between UPDRS scores and MST metrics can point toward MST metric’s utility in tracking
the disease, as UPDRS is used for long-term study of PD by clinicians [9].
To this end, the Spearman rank correlation [80] was used to study the correlation of changes
in UPDRS scores and changes in metric values after taking Levodopa. The correlations were
computed for each metric for every frequency band. The Spearman rank correlation is a nonparametric measure of rank correlation, similar to Pearson correlation, but with the difference
that it can also find non-linear relationships between two variables. Specifically, the Spearman
correlation determines if two variables have a monotonic relationship or not. Two variables
have a monotonic relationship if (1) one variable increases as the other one increases; (2) one
variable decreases as the other one increases. The Spearman rank can determine both the
existence and strength of such relationships between variables [80].

3.7. Results

3.7

43

Results

The analysis showed that in the lower α band, DM and the avgECC were significantly higher
after Levodopa intake, as can be seen in Fig. 3.1. Also, lower α maxBC decreased marginally
while not passing the statistical significance threshold. The detailed results of this analysis are
shown in Table. 3.3 and Fig. 3.3. There were no significant changes in the average PLI of any
frequency band (See Table. 3.2).
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Figure 3.1: Box plots of network metrics in the lower α band that significantly changed after
Levodopa intake

Although no significant correlations were found between change in metrics and change
in UPDRS scores, multiple marginal correlations were found in lower α and β bands. This
includes TH and maxBC in the lower α band and LF in the β band. These results too can be
seen in Table. 3.3.

44

Chapter 3. Graph Network Modulation of Levodopa in Parkinson’s Patients

Table 3.2: Hypothesis testing results for changes in the average PLI of each frequency band
after Levodopa intake.
Frequency
Band
δ
θ
Lower α
Upper α
β

3.8

Metric

p-value

Average
PLI

0.8094
0.4183
0.6619
0.2721
0.5645

Discussion

This study examined whether topological changes in the brain networks of PD patients after
Levodopa intake could be identified by using MST analysis on their resting-state EEG data.
The results presented here confirm differences in the organization of the brain networks of
PD patients before and after patients take Levodopa, as seen through significant changes in
their MST metrics in the lower α band. These changes signal a reorganization of PD patients’
brain networks toward more path-like networks. Furthermore, it is observed that traditional
methods such as PLI connectivity fail to detect these changes (See Table. 3.2). This observation
validates the utility of MST analysis of resting-state EEG of PD patients by capturing specific
characteristics of the brain networks that conventional FC analysis fails to do. Finally, marginal
associations in the lower α and β bands were also observed between changes in MST metrics
and changes in UPDRS scores of PD patients after Levodopa intake, suggesting the possibility
that MST metrics can track the severity of PD symptoms.

3.8.1

Effects of Levodopa on Network Reorganization

From a network optimality perspective, trees achieve optimal performance by exhibiting two
characteristics; efficient communication between nodes and a topology in which no central
or hub nodes are overloaded [44]. These two aspects of a network can be quantified with
small values for DM and maxBC. As discussed in Chapter 2, DM measures the efficiency of
long-range communication between the nodes in an MST, and BC measures the importance
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Table 3.3: Hypothesis testing results for comparing PD patients off and on Levodopa. Changes
in network metrics and the correlation of these metrics to changes in UPDRS values were
tested. Entries in Bold are p-values that were statistically significant after FDR correction,
while those with * are marginally significant with p-values < 0.05.
Frequency
band

δ

θ

Lower α

Upper α

β

Metric
maxDG
DM
avgECC
LF
TH
maxBC
maxDG
DM
avgECC
LF
TH
maxBC
maxDG
DM
avgECC
LF*
TH*
maxBC*
maxDG
DM
avgECC
LF
TH
maxBC
maxDG
DM
avgECC
LF*
TH
maxBC

Wilcoxon’s
Signed Rank test
p-value
0.9890
0.2441
0.3519
0.5029
0.5695
0.5014
0.5127
0.5891
0.3255
0.4620
0.6791
0.5870
0.0781
0.0101
0.0121
0.1328
0.0703
0.0362
0.1982
0.3323
0.3519
0.5930
0.6051
0.3011
0.3730
0.5435
0.5340
0.8079
0.9176
0.8766

Spearman’s
Rank Correlation
R
p-value
-0.1905
0.4797
-0.2037
0.4492
-0.2193
0.4145
-0.0333
0.9025
0.0103
0.9698
-0.0979
0.7182
-0.0275
0.9194
0.1622
0.5484
0.2159
0.4219
-0.2249
0.4024
-0.1074
0.6921
-0.2106
0.4337
0.3640
0.1658
-0.2660
0.3194
-0.3326
0.2081
-0.5455* 0.0288*
-0.6269* 0.0093*
0.5136* 0.0419*
0.0777
0.7748
-0.0629
0.8171
-0.0427
0.8753
-0.3664
0.1628
-0.2399
0.3709
-0.0633
0.8159
-0.1675
0.5353
0.2504
0.3496
0.2031
0.4506
-0.6177* 0.0108*
-0.4106
0.1142
-0.1546
0.5674
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(centrality) of a node in the network. ECC also plays an important role, as it is linked to both
DM and maxBC. DM can be defined as the maximum ECC, while lower values of ECC for a
node point toward its higher centrality [42, 44].
The observed increase in DM and avgECC after Levodopa intake (See Fig. 3.1) indicates
a decrease in the global efficiency of patients’ brain networks, a trend from star-like networks
with more central nodes to path-like networks that are more decentralized. A marginally significant decrease in the maxBC was also observed (See Fig. 3.3(f)), again signaling a change
to a network with less prominent central nodes, similar to a path tree [44].
These results can also be observed by visualizing the lower α average MSTs, which can be
observed in Fig. 3.2. In Fig. 3.2(a) and Fig. 3.2(b) we can see how the CP2 electrode that was
a star-like hub node before subjects took Levodopa loses links after Levodopa intake. In these
figures, we can see how the average network changes from a star-like tree to a path-like one.
This decrease in the integration of the brain networks is remarkable, as Levodopa appears
to have a negative effect on the optimality of brain networks. As we explained in Section 1.3.1,
Levodopa does have adverse side effects, such as LID, even though it improves the symptoms
of PD patients. The observed loss of optimality of the MST networks in the present results
can be taken as evidence of Levodopa’s side effects, opening up a new avenue of research for
studying its effects on PD patients.
The significant changes mentioned above in network topology were observed in the lower
α band. This observation is in line with previous research, as the α band and its sub-bands
have been linked to PD and Levodopa in the literature. Existing research has shown that α
band oscillations are related to visuospatial attention of healthy subjects [81], a mechanism
that deteriorates in PD patients [82]. In a task-based MEG study of visuospatial attention in
PD patients both on and off Levodopa, Wittenberg et al. [83] reported suppressing of α band
power during the task, which was decreased when patients were on Levodopa. In a similar
MEG study of visual attention, Van Dijk et al. [84] also reported that the α band was linked
to PD and that Levodopa had a normalizing effect on α band power. This commonality with
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Figure 3.2: Illustration of connectivity changes in the lower α band before and after taking
Levodopa averaged across subjects.
the present study shows that MST methods in a resting-state EEG setting can capture similar
changes in brain activity due to PD and Levodopa as the much more expensive and difficult
studies using task-based MEG experiments.

3.8.2

Correlation of Change in MST Metrics and UPDRS Scores

As mentioned in the results, multiple MST metrics in the lower α and β bands correlate with
marginally significant changes in the UPDRS scores of patients after Levodopa intake (Table.
3.3). While not significant, these trends in the lower α and β bands are in accordance with
the literature. The β band, in particular, has been linked to motor impairment in PD and its
improvement following both Levodopa and DBS [85, 86, 39]. The α band too has been reported
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to be correlated to neuropsychometric tests in PD [87]. Next, we will cover a few such studies.

3.8.3

Comparison with the Existing Literature

Comparing the results of the present study with the existing literature on Levodopa, we can see
that the β band and lower α bands are similarly reported as two crucial correlates of how clinical
symptoms of patients are affected by Levodopa. It can also be seen that using MST methods on
resting-state EEG data can give similar results to those observed through fMRI and MEG for
a fraction of the cost and provide more in-depth information compared to conventional EEG
analysis methods. Next, we will review some of this work.
Melgari et al. [88] compared absolute EEG power in different frequency bands in a restingstate setting before and after Levodopa intake. They found that α and β rhythms significantly
increased after taking Levodopa. They also reported that activity in these bands correlated
with UPDRS subscores. Their results agree with ours as far as the affected frequency bands
are concerned. However, their methods cannot give us any information about the change in the
brain networks of PD patients, which is possible with our results based on MSTs.
Berman et al. [89] used resting-state fMRI and graph metrics to study how Levodopa modulated the brain. They did not find any significant changes in the network as a whole. However,
they reported that specific subnetworks showed a change toward a more small-world-like network after Levodopa intake. Weinberger et al. [90] analyzed neuronal spike activity and LFP
from STN of PD patients, observing that Levodopa intake decreased β activity, which is increased in PD patients compared with controls. In a resting-state EEG study of PD patients
before and after Levodopa intake, using the source localization technique eLORETA, Babiloni
et al. [91] reported a reduction in source activations in the δ and α band. Cao et al. [92] studied
the effects of Levodopa on resting-state MEG of PD symptoms. While we did not see any significant changes in the δ bands, and changes in the β band were marginal, the α band changes
seem to be a common factor in our study and the literature. Furthermore, our results align with
studies done with much more expensive and complex neuroimaging methods such as MEG and
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fMRI, which points to the usability of our method.
Schneider et al. [93] recorded resting-state high-density EEG from PD patients on and off
Levodopa, in addition to healthy control subjects. They used a modified source localization
method from individual MRIs to not be confined to a set of predefined ROIs, similar to the
other source localization papers mentioned above. With this method, they were also able to
do whole-brain network analysis at different frequency bands. Based on previous literature,
their focus was on how β frequency activity would change. Their results showed a normalizing
behaviour associated with Levodopa intake, increasing functional connectivity in β and gamma
bands when comparing off and on Levodopa patients to controls. Maitı́n et al. [94] similarly
looked at resting-state and a motor task EEG of six off and on Levodopa patients and six
healthy controls, using a coherence-based time series analysis with three metrics: spectral
entropy correlation, coherence, and interhemispheric divergence. They stated that PD patients
showed higher connectivity between regions relative to controls, which was mitigated when
they took Levodopa. While they saw significant changes in the motor task, they failed to
observe any significant changes in the resting-state data. As mentioned in our literature review
in Chapter 1, Evangelisti et al. also conducted a similar resting-state EEG-fMRI study using
source localization techniques to investigate how Levodopa affects PD patients. They, too,
failed to see any significant changes in the EEG data. Both Maitı́n et al. and Evangelisti et al.
used recorded data from smaller subject populations, which could explain their failure to see
any changes. Nevertheless, this also suggests the superiority of MST methods in the study of
resting-state EEG data.
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(a) maxDG

(b) DM

(c) avgECC

(d) LF
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(e) TH

(f) maxBC

Figure 3.3: Boxplots of network metrics before and after taking Levodopa. Each row visualizes
how the distribution of a metric changes before and after subjects took Levodopa per frequency
band. This data was tested using Wilcoxon’s Sign Rank test, the results of which is given in
Table 3.3.
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Conclusion

In this study, we showed that using MST methods with resting-state EEG can help to identify
significant changes in the functional brain networks of PD patients in the lower α frequency
band after taking Levodopa. Levodopa intake is linked to a change in the brain networks
toward a more path-like network, suggesting a decrease in the efficiency of long-range paths in
the network.

Chapter 4
Concluding Remarks

4.1

Contributions and Future Directions

The aim of this thesis was to perform an MST network-based analysis of resting-state EEG
data for studying the effects of Levodopa intake in PD patients. To this end, we used MSTs for
their robustness to bias and reproducibility compared to conventional graph and connectivity
methods and their ability to quantify changes in whole-brain network connectivity, which pairwise comparison of network nodes in standard functional connectivity studies cannot do. The
results show that Levodopa intake changes MST network of PD patients in the lower α band
toward more path-like and less integrated networks. A trend toward a less optimal network is
seen, manifested by a decrease in the importance of central nodes and the efficiency of longrange connections in the network. This result is aligned with studies suggesting a mixed effect
of Levodopa.
In the first chapter, we introduced the importance of Levodopa in treating PD, covering
its positive and negative effects on patients. We also presented a general pipeline for studying
these effects at a network level with EEG. Chapter 2 was dedicated to a comprehensive study of
the pipeline, covering both practical and theoretical considerations, with a detailed discussion
of graph and MST analyses and the advantages of MST analysis over conventional methods.
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In the third chapter, we delineated our study design based on resting-state EEG data of PD
patients before and after taking Levodopa and reported our results. For the first time, it was
shown that resting-state EEG could identify significant changes in tree-based functional brain
networks of PD patients in the lower α frequency band using tree analysis and graph theory
after taking Levodopa.
It should be noted that although some changes in raw EEG activity in the α band have been
reported in the literature [88], the EEG modulation effect of Levodopa in α band connectivity
has not been successfully investigated through network analysis. In addition to the main result,
we also observed a marginally significant correlation between multiple tree measures in the
lower α and β bands and a change in UPDRS scores. In conclusion, our study showed that a
combination of resting-state EEG connectivity with MST analysis could reveal how Levodopa
changes the brain networks of PD patients in a nonlinear manner.
Based on the contributions of this thesis, we can envision several research directions to
explore. The immediate continuation of our work is to collect data from healthy controls and
use our pipeline to compare MST metric changes between patients and control subjects. From
this comparison, we can learn if taking Levodopa has a normalizing effect on brain networks
toward the brain network of control subjects or whether it moves the networks away from
healthy brains networks. This could help us to see whether the observed loss of optimality in
the networks is connected to the adverse side effects of Levodopa. Furthermore, we can use
our methods to study the long-term effects of Levodopa on brain networks and how it relates
to the progression of the disease and change in dosage of the medication. Another extension
of the current study would be to perform regional analysis of networks, which can be done
by combining EEG and MRI imaging to identify specific interactions between brain regions
after Levodopa intake. To improve our current method and address its limitations, we could
increase the subject population and use higher density EEG devices with a much larger number
of electrodes.
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